List of works - Bernard Lammek

Analogs of arginine vasopressin modified in the N-terminal part of the molecule with a conformationally constrained cis-peptide bond motif

scientific article published on 01 February 2007

Analogues of AVP modified in the N-terminal part of the molecule with Pip isomers: TFA-catalysed peptide bond hydrolysis

scientific article published in March 2009

Analogues of arginine vasopressin modified at position 2 with proline derivatives: selective antagonists of oxytocin in vitro.

scientific article published in January 2009

Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments

scientific article published in February 2005

Analogues of arginine vasopressin modified in the N-terminal part of the molecule with pipecolic acid isomers.

scientific article published in January 2009

Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule

scientific article published on 01 March 2006

Arginine vasopressin and its analogues--the influence of position 2 modification with 3,3-diphenylalanine enantiomers. Highly potent V2 agonists.

scientific article published in July 2009

Conformational studies of vasopressin analogues modified with N-methylphenylalanine enantiomers in dimethyl sulfoxide solution

scientific article published on 01 August 2006

Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists.

scientific article

Design, synthesis and structure-activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2.

scientific article published in March 2013

Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor

scientific article published on 18 December 2013

Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin

scientific article published in November 2004

Influence of conformationally constrained amino acids replacing positions 2 and 3 of arginine vasopressin (AVP) and its analogues on their pharmacological properties

scientific article published on 01 January 2007

Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties.

scientific article published in January 2005

Investigation of cis/trans ratios of peptide bonds in AVP analogues containing N-methylphenylalanine enantiomers.

scientific article

New acylated bradykinin analogues: effect on rat blood pressure and rat uterus.

scientific article published in July 2005

New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid

scientific article

Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents.

scientific article published on 3 January 2012

Novel analogues of arginine vasopressin containing alpha-2-indanylglycine enantiomers in position 2.

scientific article

Novel analogues of bradykinin conformationally restricted in the C-terminal part of the molecule

scientific article published on 15 March 2011

Raman and surface-enhanced Raman spectroscopy investigation of vasopressin analogues containing 1-aminocyclohexane-1-carboxylic acid residue

scientific article

Solution structure of conformationally restricted vasopressin analogues

scientific article published on January 2004

Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor

scientific article

The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells

scientific article

The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist

scientific article published on 15 May 2007

The influence of 1-aminocyclopentane-1-carboxylic acid at position 2 or 3 of AVP and its analogues on their pharmacological properties

scientific article published in September 2005

The influence of modification at position 2 on the side-chain conformation in oxytocin analogs

scientific article published on 7 March 2006

List of works by Bernard Lammek

Analogs of arginine vasopressin modified in the N-terminal part of the molecule with a conformationally constrained cis-peptide bond motif

Analogues of AVP modified in the N-terminal part of the molecule with Pip isomers: TFA-catalysed peptide bond hydrolysis

Analogues of arginine vasopressin modified at position 2 with proline derivatives: selective antagonists of oxytocin in vitro.

Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments

Analogues of arginine vasopressin modified in the N-terminal part of the molecule with pipecolic acid isomers.

Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule

Arginine vasopressin and its analogues--the influence of position 2 modification with 3,3-diphenylalanine enantiomers. Highly potent V2 agonists.

Conformational studies of vasopressin analogues modified with N-methylphenylalanine enantiomers in dimethyl sulfoxide solution

Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists.

Design, synthesis and structure-activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2.

Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor

Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin

Influence of conformationally constrained amino acids replacing positions 2 and 3 of arginine vasopressin (AVP) and its analogues on their pharmacological properties

Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties.

Investigation of cis/trans ratios of peptide bonds in AVP analogues containing N-methylphenylalanine enantiomers.

New acylated bradykinin analogues: effect on rat blood pressure and rat uterus.

New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid

Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents.

Novel analogues of arginine vasopressin containing alpha-2-indanylglycine enantiomers in position 2.

Novel analogues of bradykinin conformationally restricted in the C-terminal part of the molecule

Raman and surface-enhanced Raman spectroscopy investigation of vasopressin analogues containing 1-aminocyclohexane-1-carboxylic acid residue

Solution structure of conformationally restricted vasopressin analogues

Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor

The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells

The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist

The influence of 1-aminocyclopentane-1-carboxylic acid at position 2 or 3 of AVP and its analogues on their pharmacological properties

The influence of modification at position 2 on the side-chain conformation in oxytocin analogs

Unusual gain in the coordination ability of vasopressin-like peptides towards Cu2+ ions by insertion of the highly hydrophobic side chain